Supermoon Capital, formerly SleepScore Ventures, a venture capital firm focused on investing in early-stage startups advancing solutions for healthier sleep, launched with its first venture fund of $36m.
Investors include ResMed (NYSE: RMD), a global leader in digital health and the number one provider of connected devices to treat sleep apnea, among others.
The vehicle will invest in early-stage startups across all geographies working on science-backed innovations aimed to improve sleep.
Co-founded by Pat Connolly, Michael Masterson and Grayson Judge, Supermoon Capital aims to address the category of the Night Market™, the firm’s name for addressing the $488 billion sleep economy. The firm applies advanced sleep science to inform its investment process and support its portfolio companies.
To date, Supermoon Capital has invested in six early-stage startups comprising a global portfolio that spans a range of technology sectors and industries — such as software, medical devices, hardware, and services for clinical and consumer use — and includes:
- Clair Labs (Tel Aviv, Israel), a provider of patient monitoring for remote healthcare by developing contact-free technology for clinical-grade physiological monitoring.
- Endel (Berlin, Germany): a provider of AI-generated, personalized soundscapes for circadian optimization that improve sleep, reduce stress, and boost productivity.
- EnsoData (Madison, Wisconsin, U.S.): which helps clinicians diagnose sleep apnea and other sleep disorders with its FDA-cleared AI software that analyzes medical waveform data.
- FreshBed (Amsterdam, The Netherlands): A scientifically-designed bed system that regulates air quality, temperature, humidity, and ergonomic comfort for optimal sleep.
FinSMEs
27/08/2021